Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000902664-25-001334
Filing Date
2025-03-04
Accepted
2025-03-04 17:56:37
Documents
1
Period of Report
2025-02-28

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 8480
  Complete submission text file 0000902664-25-001334.txt   11391
Mailing Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272
Business Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272 424-473-8055
Aadi Bioscience, Inc. (Issuer) CIK: 0001422142 (see all company filings)

EIN.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 110 GREENE STREET SUITE 800 NEW YORK NY 10012
Business Address 110 GREENE STREET SUITE 800 NEW YORK NY 10012 212-937-4975
Avoro Capital Advisors LLC (Reporting) CIK: 0001633313 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38560 | Film No.: 25707057

Mailing Address C/O AVORO CAPITAL ADVISORS LLC 110 GREENE STREET, SUITE 800 NEW YORK NY 10012
Business Address
Aghazadeh Behzad (Reporting) CIK: 0001701815 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38560 | Film No.: 25707058

Mailing Address 110 GREEN STREET, SUITE 800 NEW YORK NY 10012
Business Address 110 GREEN STREET, SUITE 800 NEW YORK NY 10012 (212) 937-4975
Avoro Ventures LLC (Reporting) CIK: 0001879253 (see all company filings)

State of Incorp.: DE
Type: 4 | Act: 34 | File No.: 001-38560 | Film No.: 25707056